首页 > 最新文献

中华眼外伤职业眼病杂志最新文献

英文 中文
The efficacy of pedicled rotative flap in repairing eyelid defects after resection of eyelid tumors 带蒂旋转皮瓣修复眼睑肿瘤切除后眼睑缺损的疗效观察
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.015
Mengfei Hu
Objective To evaluate the clinical efficacy of pedicled rotative flap in repairing eyelid defects after eyelid tumors resection. Methods The clinical data of 61 eyes of 50 cases with eyelid tumor were retrospectively analyzed. One or more pedicled flaps were used to repair eyelid defect after eyelid tumors resection. These patients were followed up for 6 months. Results All the flaps were survived with the normal appearance and the incision were primary healing. At the last follow-up, there was no tumor reccurred. The eyelid closure function was good and all patients were satisfied with the appearance of eyelid. Conclusion Application of pedicled rotative flap to repair eyelid defects after eyelid tumors resection is a simple, safe and effective method. Key words: Tumor, eyelid; Defect, eyelid; Repair, transplantation, flap, pedicled, rotative
目的探讨带蒂旋转皮瓣修复眼睑肿瘤切除后眼睑缺损的临床疗效。方法回顾性分析50例61眼眼睑肿瘤的临床资料。应用带蒂皮瓣修复眼睑肿瘤切除后的缺损。随访6个月。结果皮瓣全部成活,外观正常,切口初步愈合。最后一次随访未见肿瘤复发。术后眼睑闭合功能良好,患者对眼睑外观满意。结论应用带蒂旋转皮瓣修复眼睑肿瘤切除后眼睑缺损是一种简便、安全、有效的方法。关键词:肿瘤;眼睑;眼睑缺损;修复,移植,皮瓣,带蒂,旋转
{"title":"The efficacy of pedicled rotative flap in repairing eyelid defects after resection of eyelid tumors","authors":"Mengfei Hu","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.015","url":null,"abstract":"Objective \u0000To evaluate the clinical efficacy of pedicled rotative flap in repairing eyelid defects after eyelid tumors resection. \u0000 \u0000 \u0000Methods \u0000The clinical data of 61 eyes of 50 cases with eyelid tumor were retrospectively analyzed. One or more pedicled flaps were used to repair eyelid defect after eyelid tumors resection. These patients were followed up for 6 months. \u0000 \u0000 \u0000Results \u0000All the flaps were survived with the normal appearance and the incision were primary healing. At the last follow-up, there was no tumor reccurred. The eyelid closure function was good and all patients were satisfied with the appearance of eyelid. \u0000 \u0000 \u0000Conclusion \u0000Application of pedicled rotative flap to repair eyelid defects after eyelid tumors resection is a simple, safe and effective method. \u0000 \u0000 \u0000Key words: \u0000Tumor, eyelid; Defect, eyelid; Repair, transplantation, flap, pedicled, rotative","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86996215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of OCT angiography of macular epiretinal membrane after vitrectomy 玻璃体切除术后黄斑视网膜前膜OCT血管造影分析
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.010
Feng-mei Han, Kun Li, Yuyan Liu, Dongqing Liang, Q. Han
Objective To analyze the changes of macular capillaries in patients with idiopathic macular epiretinal membrane (IMEM) after vitrectomy. Methods A retrospective study. The clinical data of 33 eyes of 33 cases with IMEM after vitrectomy and internal limiting membrane peeling from May 2015 to Jul. 2017 in Tianjin Eye Hospital were collected. All patients were diagnosed with optical coherence tomography angiography (OCTA) and followed-up for 12 months. Results The BCVA (logMAR) after surgery was improved from 0.700±0.309 to 0.252±0.182 (t=7.212, P=0.000), while central macular thickness (CMT) was decreased from (447.44±96.96)μm to (373.56±82.36) μm after surgery (t=8.247, P=0.000), and foveal avascular zone (FAZ) was increased from (0.120±0.059)mm2 to (0.145±0.063)mm2 (t=6.660, P=0.000). The macular vascular density (MVD) in the superficial and deep macular area examined with OCTA were increased significantly (P<0.05). There was a negative correlation between BCVA and CMT (r=-0.507, P=0.014), while a positive correlation between BCVA and deep MVD (r=0.578, P=0.024). Conclusion Microvascular changes in macular area are quantitatively detected with OCTA, and FAZ and MVD increase in patients after IMEM vitrectomy. Key words: Membrane, epiretinal, macular; Vitrectomy; Injuries, microvessls; Tomography, vascular, optical coherence
目的分析特发性黄斑视网膜前膜(IMEM)患者玻璃体切除术后黄斑毛细血管的变化。方法回顾性研究。收集2015年5月至2017年7月天津市眼科医院玻璃体切除及内限定膜剥离术后33只眼的IMEM患者的临床资料。所有患者均行光学相干断层血管造影(OCTA)诊断并随访12个月。结果术后BCVA (logMAR)由0.700±0.309改善至0.252±0.182 (t=7.212, P=0.000),黄斑中央厚度(CMT)由(447.44±96.96)μm降至(373.56±82.36)μm (t=8.247, P=0.000),中央凹无血管区(FAZ)由(0.120±0.059)mm2改善至(0.145±0.063)mm2 (t=6.660, P=0.000)。OCTA检查黄斑浅、深区血管密度(MVD)均显著升高(P<0.05)。BCVA与CMT呈负相关(r=-0.507, P=0.014), BCVA与深部MVD呈正相关(r=0.578, P=0.024)。结论OCTA定量检测了IMEM玻璃体切除术后黄斑微血管的变化,FAZ和MVD升高。关键词:膜,视网膜前,黄斑;玻璃体切除术;受伤,microvessls;断层扫描,血管,光学相干
{"title":"Analysis of OCT angiography of macular epiretinal membrane after vitrectomy","authors":"Feng-mei Han, Kun Li, Yuyan Liu, Dongqing Liang, Q. Han","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.010","url":null,"abstract":"Objective \u0000To analyze the changes of macular capillaries in patients with idiopathic macular epiretinal membrane (IMEM) after vitrectomy. \u0000 \u0000 \u0000Methods \u0000A retrospective study. The clinical data of 33 eyes of 33 cases with IMEM after vitrectomy and internal limiting membrane peeling from May 2015 to Jul. 2017 in Tianjin Eye Hospital were collected. All patients were diagnosed with optical coherence tomography angiography (OCTA) and followed-up for 12 months. \u0000 \u0000 \u0000Results \u0000The BCVA (logMAR) after surgery was improved from 0.700±0.309 to 0.252±0.182 (t=7.212, P=0.000), while central macular thickness (CMT) was decreased from (447.44±96.96)μm to (373.56±82.36) μm after surgery (t=8.247, P=0.000), and foveal avascular zone (FAZ) was increased from (0.120±0.059)mm2 to (0.145±0.063)mm2 (t=6.660, P=0.000). The macular vascular density (MVD) in the superficial and deep macular area examined with OCTA were increased significantly (P<0.05). There was a negative correlation between BCVA and CMT (r=-0.507, P=0.014), while a positive correlation between BCVA and deep MVD (r=0.578, P=0.024). \u0000 \u0000 \u0000Conclusion \u0000Microvascular changes in macular area are quantitatively detected with OCTA, and FAZ and MVD increase in patients after IMEM vitrectomy. \u0000 \u0000 \u0000Key words: \u0000Membrane, epiretinal, macular; Vitrectomy; Injuries, microvessls; Tomography, vascular, optical coherence","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76733783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances of internal limiting membrane peeling in the treatment of myopic traction maculopathy 内限制膜剥离治疗近视牵引性黄斑病变的进展
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.016
Mengdi Li, Xuemin Jin
The internal limiting membrane(ILM) is located in the innermost layer of the retinal neuroepithelium, which is the basement membrane of Muller cells.In myopic retinopathy, ILM forms forward traction to the retina and causes the myopic traction maculopathy (MTM). In previous clinical studies, MTM is treated with pars plana vitrectomy(PPV) combined with ILM peeling, reversal and tamping, etc. The rate of retinal reattachment, macular hole closure and visual acuity improvement are different in different treatments. In this paper the pathological changes of the ILM in MTM, and the treatment methods of ILM during vitrectomy will be reviewed. Key words: Maculopathy, traction, myopic; Vitrectomy; Peeling, membrane, limiting, internal; Tamp, membrane, limiting, internal
内限定膜(ILM)位于视网膜神经上皮的最内层,是Muller细胞的基底膜。在近视视网膜病变中,ILM对视网膜形成前向牵引力,引起近视牵引力黄斑病变(MTM)。在以往的临床研究中,MTM的治疗多采用玻璃体切除(PPV)联合内膜剥离、反转、夯实等方法。不同治疗方法的视网膜复植率、黄斑孔闭合率和视力改善率不同。本文就MTM中ILM的病理变化及玻璃体切除术中ILM的治疗方法作一综述。关键词:黄斑病变;牵引;近视;玻璃体切除术;去皮、膜、限位、内;泵,膜,限位,内部
{"title":"Advances of internal limiting membrane peeling in the treatment of myopic traction maculopathy","authors":"Mengdi Li, Xuemin Jin","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.016","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.016","url":null,"abstract":"The internal limiting membrane(ILM) is located in the innermost layer of the retinal neuroepithelium, which is the basement membrane of Muller cells.In myopic retinopathy, ILM forms forward traction to the retina and causes the myopic traction maculopathy (MTM). In previous clinical studies, MTM is treated with pars plana vitrectomy(PPV) combined with ILM peeling, reversal and tamping, etc. The rate of retinal reattachment, macular hole closure and visual acuity improvement are different in different treatments. In this paper the pathological changes of the ILM in MTM, and the treatment methods of ILM during vitrectomy will be reviewed. \u0000 \u0000 \u0000Key words: \u0000Maculopathy, traction, myopic; Vitrectomy; Peeling, membrane, limiting, internal; Tamp, membrane, limiting, internal","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72961254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison on the efficacy of two local anaesthesia methods in vitrectomy 两种局部麻醉方法在玻璃体切除术中的疗效比较
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.008
Yunpeng Li, Dandan Li, Rui Zeng
Objective To compare the safety and efficacy of sub-tenon’s anesthesia of ropivacaine and lidocaine combined with bupivacaine retrobulbar anesthesia in vitrectomy for rhegmatogenous retinal detachment. Methods A prospective, continuous, and randomized clinical study. Total of 278 eyes of 273 patients who underwent vitrectomy for rhegmatogenous retinal detachment from Oct. 2017 to Jun. 2019 were included in the study. All patients were randomly divided into two groups. Group A, 138 eyes of 136 cases, received ropivacaine under sub-tenon’s anesthesia, 140 eyes of 137 patients in group B received lidocaine combined with bupivacaine retrobulbar anesthesia. The pain score and anesthesia related complications were compared between the two groups. Results The total pain score of group A was lower than that of group B, the difference of scores of anesthesia, scleral incision, and vitrectomy with depressed sclera was statistically significant (t=-14.894, -3.379, -5.242, P=0.000, 0.001, 0.000). In group B, 1 case had perforating injury and 6 cases had retrobulbar hemorrhage. Conclusion Sub-tenon’s anesthesia with ropivacaine is safe and effective in vitrectomy for rhegmatogenous retinal detachment. Key words: Anesthesia, sub-tenon’s; Ropivacaine; Vitrectomy; Retinal detachment, rhegmatogenous
目的比较罗哌卡因亚腱麻醉与利多卡因联合布比卡因球后麻醉在玻璃体切除术中治疗孔源性视网膜脱离的安全性和有效性。方法前瞻性、连续、随机临床研究。2017年10月至2019年6月接受玻璃体切除术治疗孔源性视网膜脱离的273例患者,共278只眼纳入研究。所有患者随机分为两组。A组136例138眼采用罗哌卡因亚tenon麻醉,B组137例140眼采用利多卡因联合布比卡因球后麻醉。比较两组患者疼痛评分及麻醉相关并发症。结果A组总疼痛评分低于B组,麻醉、巩膜切口、玻璃体切除伴巩膜凹陷组的评分差异有统计学意义(t=-14.894、-3.379、-5.242,P=0.000、0.001、0.000)。B组穿孔损伤1例,球后出血6例。结论罗哌卡因亚腱麻醉用于孔源性视网膜脱离玻璃体切除术安全有效。关键词:麻醉;亚榫;Ropivacaine;玻璃体切除术;视网膜脱离,孔源性
{"title":"Comparison on the efficacy of two local anaesthesia methods in vitrectomy","authors":"Yunpeng Li, Dandan Li, Rui Zeng","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.008","url":null,"abstract":"Objective \u0000To compare the safety and efficacy of sub-tenon’s anesthesia of ropivacaine and lidocaine combined with bupivacaine retrobulbar anesthesia in vitrectomy for rhegmatogenous retinal detachment. \u0000 \u0000 \u0000Methods \u0000A prospective, continuous, and randomized clinical study. Total of 278 eyes of 273 patients who underwent vitrectomy for rhegmatogenous retinal detachment from Oct. 2017 to Jun. 2019 were included in the study. All patients were randomly divided into two groups. Group A, 138 eyes of 136 cases, received ropivacaine under sub-tenon’s anesthesia, 140 eyes of 137 patients in group B received lidocaine combined with bupivacaine retrobulbar anesthesia. The pain score and anesthesia related complications were compared between the two groups. \u0000 \u0000 \u0000Results \u0000The total pain score of group A was lower than that of group B, the difference of scores of anesthesia, scleral incision, and vitrectomy with depressed sclera was statistically significant (t=-14.894, -3.379, -5.242, P=0.000, 0.001, 0.000). In group B, 1 case had perforating injury and 6 cases had retrobulbar hemorrhage. \u0000 \u0000 \u0000Conclusion \u0000Sub-tenon’s anesthesia with ropivacaine is safe and effective in vitrectomy for rhegmatogenous retinal detachment. \u0000 \u0000 \u0000Key words: \u0000Anesthesia, sub-tenon’s; Ropivacaine; Vitrectomy; Retinal detachment, rhegmatogenous","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72418661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Timolol application time on refractive regression after LASIK in patients with high myopia 替莫洛尔应用时间对高度近视LASIK术后屈光退化的影响
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.004
Mei Zhong, Yan-hui Bai, Wei-qun Wang
Objective To observe the effect of application time of Timolol eye drops on refractive regression after LASIK in patients with high myopia. Methods A prospective case study.The data of 64 eyes of 32 patients with high myopia who underwent LASIK from Jan.2017 to Dec.2018 in the First Affiliated Hospital of Zhengzhou University were analyzed.All cases were randomly divided into the clinical trial group and the control group, 32 eyes of 32 cases in each group.All cases were selected one eye after surgery as the observation object.All cases received the conventional antibiotic eye drops combined with Timolol eye drops at 1 day after surgery.The Timolol eye drops in trial group were continuously dripped for 3 months, and the control group were dripped for 1 month.The two groups were followed up for 6 months. Results There was no significant difference in the visual acuity, intraocular pressure, refractive status equivalent spherical degree (SE) and corneal anterior shift (Diff value) between the two groups at 1 week and 1 month after operation(P>0.05). The difference of uncorrected visual acuity, refractive status (SE) and corneal anterior volume in the clinical trial group at 3 and 6 months after operation were better than those in the control group (t=7.030, 3.250, P=0.000, 0.010). Conclusion Application of Timolol eye drops after LASIK for 3 months can prevent refractive retraction after high myopia. Key words: Myopia, high; LASIK; Regression, refractive; Timolol; Pressure, intraocular
目的观察噻咪洛尔滴眼液应用时间对高度近视LASIK术后屈光退化的影响。方法前瞻性案例研究。分析2017年1月至2018年12月在郑州大学第一附属医院行LASIK手术的32例高度近视患者64只眼的资料。所有病例随机分为临床试验组和对照组,每组32例32眼。所有病例均选择术后一只眼作为观察对象。所有病例均于术后1天使用常规抗生素滴眼液联合替莫洛尔滴眼液。试验组连续滴注替莫洛尔滴眼液3个月,对照组连续滴注1个月。两组患者随访6个月。结果两组患者术后1周、1个月的视力、眼压、屈光状态、等效球度(SE)、角膜前移(Diff值)比较,差异均无统计学意义(P>0.05)。临床试验组术后3、6个月的未矫正视力、屈光状态(SE)及角膜前体积差异均优于对照组(t=7.030、3.250,P=0.000、0.010)。结论在LASIK术后应用替莫洛尔滴眼液3个月可预防高度近视屈光回缩。关键词:近视,高度;LASIK手术;回归,折射;Timolol;压力,眼内
{"title":"Effect of Timolol application time on refractive regression after LASIK in patients with high myopia","authors":"Mei Zhong, Yan-hui Bai, Wei-qun Wang","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.004","url":null,"abstract":"Objective \u0000To observe the effect of application time of Timolol eye drops on refractive regression after LASIK in patients with high myopia. \u0000 \u0000 \u0000Methods \u0000A prospective case study.The data of 64 eyes of 32 patients with high myopia who underwent LASIK from Jan.2017 to Dec.2018 in the First Affiliated Hospital of Zhengzhou University were analyzed.All cases were randomly divided into the clinical trial group and the control group, 32 eyes of 32 cases in each group.All cases were selected one eye after surgery as the observation object.All cases received the conventional antibiotic eye drops combined with Timolol eye drops at 1 day after surgery.The Timolol eye drops in trial group were continuously dripped for 3 months, and the control group were dripped for 1 month.The two groups were followed up for 6 months. \u0000 \u0000 \u0000Results \u0000There was no significant difference in the visual acuity, intraocular pressure, refractive status equivalent spherical degree (SE) and corneal anterior shift (Diff value) between the two groups at 1 week and 1 month after operation(P>0.05). The difference of uncorrected visual acuity, refractive status (SE) and corneal anterior volume in the clinical trial group at 3 and 6 months after operation were better than those in the control group (t=7.030, 3.250, P=0.000, 0.010). \u0000 \u0000 \u0000Conclusion \u0000Application of Timolol eye drops after LASIK for 3 months can prevent refractive retraction after high myopia. \u0000 \u0000 \u0000Key words: \u0000Myopia, high; LASIK; Regression, refractive; Timolol; Pressure, intraocular","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85796190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of clinical efficacy between I phase and II phase intraocular lens implantation for the treatment of traumatic cataract 一期与二期人工晶状体植入术治疗外伤性白内障的临床疗效比较
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.002
T. Peng, Dandan Yu
Objective To compare the clinical efficacy between Ⅰ and Ⅱ phase IOL implantation for the treatment of traumatic cataract. Methods Fifty patients of monocular traumatic cataract from Jan. 2016 to Jan. 2018 in Zhejiang Armed Police Corps Hospital were selected.All cases were randomly divided into two groups.There were Ⅰ phase IOL implantation group of 28 cases and Ⅱ phase IOL implantation group of 22 cases.The efficacy of the two groups was compared. Results One month after operation, the visual acuity of the two groups were significantly better than that before operation (P 0.05). One month after operation, the incidence of corneal edema, uveitis, posterior synechia and secondary glaucoma in II stage group were lower than that in I stage group (P<0.05). One year after operation, the anterior chamber depth and scores of tear film rupture time in Ⅱ phase group were higher than those in Ⅰ phase group (P<0.05), and the intraocular pressure and scores of corneal fluorescence staining were lower than those in Ⅰ phase group (P<0.05). Conclusion IOL implantation, the complication rate of the Ⅱ phase of traumatic cataract for the treatment is lower and the long-term effect is better. Key words: Cataract, traumatic; Implantation, lens, intraocular; Efficacy, clinical
目的比较Ⅰ与Ⅱ相人工晶状体植入术治疗外伤性白内障的临床疗效。方法选取2016年1月至2018年1月武警总队医院收治的单眼外伤性白内障患者50例。所有病例随机分为两组。Ⅰ人工晶状体置入组28例,Ⅱ人工晶状体置入组22例。比较两组患者的疗效。结果术后1个月,两组患者的视力均明显优于术前(P < 0.05)。术后1个月,II期组角膜水肿、葡萄膜炎、后粘连、继发青光眼的发生率低于I期组(P<0.05)。术后1年Ⅱ期组前房深度及泪膜破裂时间评分高于Ⅰ期组(P<0.05),眼压及角膜荧光染色评分低于Ⅰ期组(P<0.05)。结论人工晶状体植入术治疗外伤性白内障Ⅱ期并发症发生率较低,远期疗效较好。关键词:白内障;外伤性;植入术、晶状体、眼内;功效、临床
{"title":"Comparison of clinical efficacy between I phase and II phase intraocular lens implantation for the treatment of traumatic cataract","authors":"T. Peng, Dandan Yu","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.002","url":null,"abstract":"Objective \u0000To compare the clinical efficacy between Ⅰ and Ⅱ phase IOL implantation for the treatment of traumatic cataract. \u0000 \u0000 \u0000Methods \u0000Fifty patients of monocular traumatic cataract from Jan. 2016 to Jan. 2018 in Zhejiang Armed Police Corps Hospital were selected.All cases were randomly divided into two groups.There were Ⅰ phase IOL implantation group of 28 cases and Ⅱ phase IOL implantation group of 22 cases.The efficacy of the two groups was compared. \u0000 \u0000 \u0000Results \u0000One month after operation, the visual acuity of the two groups were significantly better than that before operation (P 0.05). One month after operation, the incidence of corneal edema, uveitis, posterior synechia and secondary glaucoma in II stage group were lower than that in I stage group (P<0.05). One year after operation, the anterior chamber depth and scores of tear film rupture time in Ⅱ phase group were higher than those in Ⅰ phase group (P<0.05), and the intraocular pressure and scores of corneal fluorescence staining were lower than those in Ⅰ phase group (P<0.05). \u0000 \u0000 \u0000Conclusion \u0000IOL implantation, the complication rate of the Ⅱ phase of traumatic cataract for the treatment is lower and the long-term effect is better. \u0000 \u0000 \u0000Key words: \u0000Cataract, traumatic; Implantation, lens, intraocular; Efficacy, clinical","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74262727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of phacoemulsification combined with vitrectomy for macular retinoschisis in degenerative myopic cataract eyes 超声乳化术联合玻璃体切除术治疗退行性近视白内障黄斑视网膜裂的疗效观察
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.011
Yueli Li
Objective To evaluate the clinical efficacy of phacoemulsification combined with vitrectomy for macular retinoschisis in degenerative myopic cataract eyes. Methods A retrospective study. Thirty-six eyes of 36 patients with macular retinoschisis in degenerative myopic cataract eyes from Feb.2017 to Jan.2018 in Puyang Municipal Eye Hospital were divided into two groups. Group A, 16 eyes of 16 cases, were treated with phacoemulsification. Group B, 20 eyes of 20 cases, were treated with phacoemulsification combined with vitrectomy. The BCVA, macular foveal retinal thickness and macular morphology after operation were compared between the two groups. Results The BCVA of the group B were 1.12±0.20, 0.77±0.22 and 0.36±0.17 before, 3 and 6 months after operation, and that of the group A were 1.11±0.19, 0.60±0.20 and 0.51±0.18, respectively. The BCVA of group A at 3 months after operation was better than that of group B, but BCVA was lower than that of combined group at 6 months after operation, and the differences were statistically significant (t=2.397, -2.563, P=0.022, 0.015). The average thickness of macular centre retina in group B was lower than that of group A at 3 and 6 months postoperatively(t=-2.219, -2.382; P=0.033, 0.023). There was no significant difference in macular improvement rate between the two groups(χ2=0.013, P=0.909). No postoperative complication such as iatrogenic retinal breaks formation endophthalmitis or intraocular hemorrhage occurred. Conclusion Phacoemulsification combined with vitrectomy can help to improve the visual function of macular retinoschisis in degenerative myopic cataract eyes. Key words: Retinoschisis, macular; Myopia, degenerative; Vitrectomy; Phacoemulsification; Visual function
目的评价超声乳化术联合玻璃体切除术治疗退行性近视白内障黄斑视网膜裂的临床疗效。方法回顾性研究。选取濮阳市眼科医院2017年2月~ 2018年1月36例退行性近视白内障黄斑视网膜裂患者36只眼分为两组。A组16例16眼行超声乳化术。B组20例20眼,行超声乳化术联合玻璃体切除术。比较两组术后BCVA、黄斑中央凹视网膜厚度及黄斑形态。结果B组术前、术后3、6个月BCVA分别为1.12±0.20、0.77±0.22、0.36±0.17,A组术前、3、6个月BCVA分别为1.11±0.19、0.60±0.20、0.51±0.18。A组术后3个月BCVA优于B组,术后6个月BCVA低于联合组,差异均有统计学意义(t=2.397, -2.563, P=0.022, 0.015)。术后3、6个月,B组黄斑中心视网膜平均厚度低于A组(t=-2.219, -2.382;P = 0.033, 0.023)。两组患者黄斑改善率比较,差异无统计学意义(χ2=0.013, P=0.909)。术后未发生医源性视网膜断裂、眼内炎、眼内出血等并发症。结论超声乳化术联合玻璃体切除术可改善退行性近视白内障黄斑视网膜裂的视功能。关键词:视网膜裂;黄斑;近视,退行性;玻璃体切除术;超声乳化;视觉功能
{"title":"Efficacy of phacoemulsification combined with vitrectomy for macular retinoschisis in degenerative myopic cataract eyes","authors":"Yueli Li","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.011","url":null,"abstract":"Objective \u0000To evaluate the clinical efficacy of phacoemulsification combined with vitrectomy for macular retinoschisis in degenerative myopic cataract eyes. \u0000 \u0000 \u0000Methods \u0000A retrospective study. Thirty-six eyes of 36 patients with macular retinoschisis in degenerative myopic cataract eyes from Feb.2017 to Jan.2018 in Puyang Municipal Eye Hospital were divided into two groups. Group A, 16 eyes of 16 cases, were treated with phacoemulsification. Group B, 20 eyes of 20 cases, were treated with phacoemulsification combined with vitrectomy. The BCVA, macular foveal retinal thickness and macular morphology after operation were compared between the two groups. \u0000 \u0000 \u0000Results \u0000The BCVA of the group B were 1.12±0.20, 0.77±0.22 and 0.36±0.17 before, 3 and 6 months after operation, and that of the group A were 1.11±0.19, 0.60±0.20 and 0.51±0.18, respectively. The BCVA of group A at 3 months after operation was better than that of group B, but BCVA was lower than that of combined group at 6 months after operation, and the differences were statistically significant (t=2.397, -2.563, P=0.022, 0.015). The average thickness of macular centre retina in group B was lower than that of group A at 3 and 6 months postoperatively(t=-2.219, -2.382; P=0.033, 0.023). There was no significant difference in macular improvement rate between the two groups(χ2=0.013, P=0.909). No postoperative complication such as iatrogenic retinal breaks formation endophthalmitis or intraocular hemorrhage occurred. \u0000 \u0000 \u0000Conclusion \u0000Phacoemulsification combined with vitrectomy can help to improve the visual function of macular retinoschisis in degenerative myopic cataract eyes. \u0000 \u0000 \u0000Key words: \u0000Retinoschisis, macular; Myopia, degenerative; Vitrectomy; Phacoemulsification; Visual function","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83223399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of conjunctival transplantation combined with lacrimal canaliculus incision for the treatment of complex upper lacrimal duct obstruction 结膜移植联合泪小管切开治疗复杂上泪管梗阻的疗效观察
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.014
Yong Zhang, Yangyang Xie, Lin Chen, Sha Li
Objective To evaluate the clinical efficacy of autologous conjunctival transplantation combined with lacrimal canaliculus incision for the treatment of complex upper lacrimal duct obstruction. Methods A retrospective study. A total of 32 eyes of 31 patients of complex upper lacrimal duct obstruction, who were treated with autologous conjunctival transplantation combined with lacrimal canaliculus incision from Feb. 2017 to Jun. 2018 in Hankou Eye Hospital of Wuhan Aier Eye Hospital were analyzed. The lacrimal passage irrigation were observed. The follow-up time was 1 year after surgery. Results At 1 year after surgery, 21 eyes(65.62%) of lacrimal passage irrigation were successful without symptom of epiphora. Lacrimal passage irrigation with partial reflux, and symptoms of epiphora occasionally occurred outdoors in 7 eyes(21.88%). Lacrimal passage irrigation with more reflux, and symptoms of epiphora improved slightly in 4 eyes(12.50%). Conclusion Autologous conjunctival transplantation combined with lacrimal canaliculus incision is effective for the treatment of complex upper lacrimal duct obstruction. Key words: Transplantation, conjunctiva, autologous; Incision, canaliculus, lacrimal; Obstruction, lacrimal duct, upper
目的探讨自体结膜移植联合泪小管切开治疗复杂性上泪管梗阻的临床疗效。方法回顾性研究。对武汉市爱尔眼科医院汉口眼科医院2017年2月至2018年6月行自体结膜移植联合泪小管切口治疗复杂上泪管梗阻的31例32眼患者进行分析。观察泪道冲洗情况。术后随访1年。结果术后1年,21眼(65.62%)泪道冲洗成功,无显泪症状。泪道冲洗伴部分反流,有7眼(21.88%)在室外偶有泪显症状。泪道冲洗返流较多,4眼(12.50%)泪显症状略有改善。结论自体结膜移植联合泪小管切开是治疗复杂上泪管阻塞的有效方法。关键词:移植,结膜,自体;泪道小管切口;阻塞,泪道,上部
{"title":"The efficacy of conjunctival transplantation combined with lacrimal canaliculus incision for the treatment of complex upper lacrimal duct obstruction","authors":"Yong Zhang, Yangyang Xie, Lin Chen, Sha Li","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.014","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.014","url":null,"abstract":"Objective \u0000To evaluate the clinical efficacy of autologous conjunctival transplantation combined with lacrimal canaliculus incision for the treatment of complex upper lacrimal duct obstruction. \u0000 \u0000 \u0000Methods \u0000A retrospective study. A total of 32 eyes of 31 patients of complex upper lacrimal duct obstruction, who were treated with autologous conjunctival transplantation combined with lacrimal canaliculus incision from Feb. 2017 to Jun. 2018 in Hankou Eye Hospital of Wuhan Aier Eye Hospital were analyzed. The lacrimal passage irrigation were observed. The follow-up time was 1 year after surgery. \u0000 \u0000 \u0000Results \u0000At 1 year after surgery, 21 eyes(65.62%) of lacrimal passage irrigation were successful without symptom of epiphora. Lacrimal passage irrigation with partial reflux, and symptoms of epiphora occasionally occurred outdoors in 7 eyes(21.88%). Lacrimal passage irrigation with more reflux, and symptoms of epiphora improved slightly in 4 eyes(12.50%). \u0000 \u0000 \u0000Conclusion \u0000Autologous conjunctival transplantation combined with lacrimal canaliculus incision is effective for the treatment of complex upper lacrimal duct obstruction. \u0000 \u0000 \u0000Key words: \u0000Transplantation, conjunctiva, autologous; Incision, canaliculus, lacrimal; Obstruction, lacrimal duct, upper","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86720578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of the mixture of sodium hyaluronate gel and triamcinolone acetonide in intraocular surgery 透明质酸钠凝胶与曲安奈德混合物在眼内手术中的应用
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.001
Xianming Deng
Objective To observe the efficacy of application of the mixture of sodium hyaluronate gel and triamcinolone acetonide(TA) in complex vitreoretinal surgery. Methods Prospective study. Total of 80 eyes of 77 patients who underwent complex vitreoretinal surgery combined with silicone oil tamponade in the First Affiliated Hospital of Zhengzhou University from May to Oct. 2018 were collected. All cases were randomly divided into treatment group and control group. At the end of surgery, the 1∶1 mixture 0.1 ml of sodium hyaluronate gel and TA (2 mg) was injected into the vitreous cavity in the treatment group; while the control group received injection of 2 mg TA into the vitreous cavity. Results The distribution of mixture was more uniform and diffuse in the silicone oil eye of treatment group, while the distribution of TA in control group was more concentrated in lumps in the silicone oil eye. The particles of TA could be completely absorbed within 2 weeks in the treatment group, while in control group TA retained for 4-8 weeks. The early postoperative BCVA improvement rate was 88.89% in the treatment group and 43.18% in control group, respectively. The difference of BCVA improvement rate was statistically significant between the two groups (χ2=19.067, P=0.000). The incidence of intraocular hypertension was 30.56% (11/36) in the treatment group and 29.55% (13/44) in control group, respectively (χ2=0.010, P=0.557). The incidence of anterior chamber fibrin exudation in the two groups was 22.22%(8/36) and 15.91% (7/44), respectively(χ2=0.518, P=0.472). The incidence of proliferative vitreoretinopathy(PVR) in the two groups was 38.89% (14/36) and 38.64% (17/44), respectively(χ2=0.001, P=0.581). Conclusion The mixture of sodium hyaluronate gel and TA is more evenly distributed and absorbed faster in the silicone oil tamponade eye. It is more conducive to the early postoperative visual recovery and fundus observation. Key words: Surgery, vitreoretinal, complex; Vitreoretinopathy, proliferative; Sodium hyaluronate; Triamcinolone acetonide; Hypertension; Anterior chamber exudation
目的观察透明质酸钠凝胶与曲安奈德(TA)混合在复杂玻璃体视网膜手术中的应用效果。方法前瞻性研究。收集2018年5月至10月在郑州大学第一附属医院行复杂玻璃体视网膜手术联合硅油填塞的患者77例80眼。所有病例随机分为治疗组和对照组。手术结束时,治疗组玻璃体腔内注射透明质酸钠凝胶与TA (2 mg) 1∶1混合物0.1 ml;对照组玻璃体腔内注射TA 2 mg。结果治疗组的混合物在硅油眼内分布较均匀,呈弥漫性分布,而对照组TA在硅油眼内以块状分布较为集中。治疗组TA颗粒可在2周内完全吸收,对照组TA保留4-8周。治疗组术后早期BCVA改善率为88.89%,对照组为43.18%。两组患者BCVA改善率差异有统计学意义(χ2=19.067, P=0.000)。治疗组和对照组高眼压发生率分别为30.56%(11/36)和29.55%(13/44),差异有统计学意义(χ2=0.010, P=0.557)。两组患者前房纤维蛋白渗出发生率分别为22.22%(8/36)、15.91%(7/44),差异有统计学意义(χ2=0.518, P=0.472)。两组患者增殖性玻璃体视网膜病变(PVR)发生率分别为38.89%(14/36)、38.64%(17/44),差异有统计学意义(χ2=0.001, P=0.581)。结论透明质酸钠凝胶与TA混合物在硅油填塞眼内分布更均匀,吸收更快。更有利于术后早期视力恢复和眼底观察。关键词:手术;玻璃体视网膜;复合体;玻璃体增殖;玻璃酸钠;去炎松醋酸酯;高血压;前房渗出
{"title":"Application of the mixture of sodium hyaluronate gel and triamcinolone acetonide in intraocular surgery","authors":"Xianming Deng","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.001","url":null,"abstract":"Objective \u0000To observe the efficacy of application of the mixture of sodium hyaluronate gel and triamcinolone acetonide(TA) in complex vitreoretinal surgery. \u0000 \u0000 \u0000Methods \u0000Prospective study. Total of 80 eyes of 77 patients who underwent complex vitreoretinal surgery combined with silicone oil tamponade in the First Affiliated Hospital of Zhengzhou University from May to Oct. 2018 were collected. All cases were randomly divided into treatment group and control group. At the end of surgery, the 1∶1 mixture 0.1 ml of sodium hyaluronate gel and TA (2 mg) was injected into the vitreous cavity in the treatment group; while the control group received injection of 2 mg TA into the vitreous cavity. \u0000 \u0000 \u0000Results \u0000The distribution of mixture was more uniform and diffuse in the silicone oil eye of treatment group, while the distribution of TA in control group was more concentrated in lumps in the silicone oil eye. The particles of TA could be completely absorbed within 2 weeks in the treatment group, while in control group TA retained for 4-8 weeks. The early postoperative BCVA improvement rate was 88.89% in the treatment group and 43.18% in control group, respectively. The difference of BCVA improvement rate was statistically significant between the two groups (χ2=19.067, P=0.000). The incidence of intraocular hypertension was 30.56% (11/36) in the treatment group and 29.55% (13/44) in control group, respectively (χ2=0.010, P=0.557). The incidence of anterior chamber fibrin exudation in the two groups was 22.22%(8/36) and 15.91% (7/44), respectively(χ2=0.518, P=0.472). The incidence of proliferative vitreoretinopathy(PVR) in the two groups was 38.89% (14/36) and 38.64% (17/44), respectively(χ2=0.001, P=0.581). \u0000 \u0000 \u0000Conclusion \u0000The mixture of sodium hyaluronate gel and TA is more evenly distributed and absorbed faster in the silicone oil tamponade eye. It is more conducive to the early postoperative visual recovery and fundus observation. \u0000 \u0000 \u0000Key words: \u0000Surgery, vitreoretinal, complex; Vitreoretinopathy, proliferative; Sodium hyaluronate; Triamcinolone acetonide; Hypertension; Anterior chamber exudation","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84375626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraocular illumination assisted scleral buckling for the treatment of simple rhegmatogenous retinal detachment 眼内照明辅助巩膜扣合治疗单纯性孔源性视网膜脱离
Pub Date : 2020-01-25 DOI: 10.3760/CMA.J.ISSN.2095-1477.2020.01.009
Zhan-sheng Shen, Yuanyuan Li, Juanjuan Yin
Objective To evaluate the efficacy of 25 G intraocular illumination assisted scleral buckling in the treatment of simple rhegmatogenous retinal detachment. Methods Retrospective case analysis. Total of 37 eyes of 37 cases with simple rhegmatogenous retinal detachment from Feb. 2016 to Oct. 2018 in Zhengzhou Second People’s hospital were included in the study. All cases underwent 25 G intraocular illumination assisted scleral buckling. The follow-up period ranged from 6 to 12 months. Results Retinal reattachment occurred in 35 eyes (94.59%) after first operation. Preoperative visual acuity ≥0.4 in 2 eyes (5.41%) increased to 12 eyes (32.43%) postoperatively. The difference was statistically significant (χ2=8.810, P=0.003). Conclusion 25 G intraocular illumination assisted scleral buckling has unique advantages.Compared with traditional scleral buckling, the surgical operation is more intuitive and accurate for the treatment of simple rhegmatogenous retinal detachment. Key words: Detachment, retinal, rhegmatogenous, simple; Buckling, scleral; Illumination, intraocular
目的评价25g眼内照明辅助巩膜扣带治疗单纯性孔源性视网膜脱离的疗效。方法回顾性病例分析。选取2016年2月至2018年10月郑州市第二人民医院37例单纯性孔源性视网膜脱离患者的37只眼作为研究对象。所有病例均行25g眼内照明辅助巩膜扣合。随访时间为6至12个月。结果首次手术后视网膜再植35眼(94.59%)。术前视力≥0.4者2眼(5.41%)术后视力≥0.4者12眼(32.43%)。差异有统计学意义(χ2=8.810, P=0.003)。结论25g眼内照明辅助巩膜扣带具有独特的优势。与传统巩膜扣带术相比,手术治疗单纯性孔源性视网膜脱离更为直观、准确。关键词:脱离;视网膜;孔源性;屈曲,巩膜的;照明,眼内
{"title":"Intraocular illumination assisted scleral buckling for the treatment of simple rhegmatogenous retinal detachment","authors":"Zhan-sheng Shen, Yuanyuan Li, Juanjuan Yin","doi":"10.3760/CMA.J.ISSN.2095-1477.2020.01.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.2095-1477.2020.01.009","url":null,"abstract":"Objective \u0000To evaluate the efficacy of 25 G intraocular illumination assisted scleral buckling in the treatment of simple rhegmatogenous retinal detachment. \u0000 \u0000 \u0000Methods \u0000Retrospective case analysis. Total of 37 eyes of 37 cases with simple rhegmatogenous retinal detachment from Feb. 2016 to Oct. 2018 in Zhengzhou Second People’s hospital were included in the study. All cases underwent 25 G intraocular illumination assisted scleral buckling. The follow-up period ranged from 6 to 12 months. \u0000 \u0000 \u0000Results \u0000Retinal reattachment occurred in 35 eyes (94.59%) after first operation. Preoperative visual acuity ≥0.4 in 2 eyes (5.41%) increased to 12 eyes (32.43%) postoperatively. The difference was statistically significant (χ2=8.810, P=0.003). \u0000 \u0000 \u0000Conclusion \u000025 G intraocular illumination assisted scleral buckling has unique advantages.Compared with traditional scleral buckling, the surgical operation is more intuitive and accurate for the treatment of simple rhegmatogenous retinal detachment. \u0000 \u0000 \u0000Key words: \u0000Detachment, retinal, rhegmatogenous, simple; Buckling, scleral; Illumination, intraocular","PeriodicalId":10126,"journal":{"name":"Chinese Journal of Ocular Trauma and Occupational Eye Disease","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81715295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华眼外伤职业眼病杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1